ATE522601T1 - Varianten von antithrombin iii - Google Patents

Varianten von antithrombin iii

Info

Publication number
ATE522601T1
ATE522601T1 AT03756385T AT03756385T ATE522601T1 AT E522601 T1 ATE522601 T1 AT E522601T1 AT 03756385 T AT03756385 T AT 03756385T AT 03756385 T AT03756385 T AT 03756385T AT E522601 T1 ATE522601 T1 AT E522601T1
Authority
AT
Austria
Prior art keywords
antithrombin iii
variants
compositions
disclosed
antithrombin
Prior art date
Application number
AT03756385T
Other languages
English (en)
Inventor
Susan Bock
Adrian Hobden
Original Assignee
Univ Utah Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Utah Res Found filed Critical Univ Utah Res Found
Application granted granted Critical
Publication of ATE522601T1 publication Critical patent/ATE522601T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins
    • C07K14/8128—Antithrombin III

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT03756385T 2002-05-31 2003-06-02 Varianten von antithrombin iii ATE522601T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38459902P 2002-05-31 2002-05-31
PCT/US2003/017506 WO2003101398A2 (en) 2002-05-31 2003-06-02 Variants of antithrombin iii

Publications (1)

Publication Number Publication Date
ATE522601T1 true ATE522601T1 (de) 2011-09-15

Family

ID=29712063

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03756385T ATE522601T1 (de) 2002-05-31 2003-06-02 Varianten von antithrombin iii

Country Status (6)

Country Link
US (1) US7482139B2 (de)
EP (1) EP1530629B1 (de)
AT (1) ATE522601T1 (de)
AU (1) AU2003243381A1 (de)
CA (1) CA2487901A1 (de)
WO (1) WO2003101398A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005206806A1 (en) * 2004-01-09 2005-08-04 University Of Utah Research Foundation Methods of using high affinity ATIII variants
WO2008127355A2 (en) * 2006-10-06 2008-10-23 Celtaxsys, Inc. Chemorepulsion of cells
WO2010081878A1 (en) * 2009-01-16 2010-07-22 Universite Paris-Sud Xi Mutated antithrombins, a process for preparing the same and their use as drugs
GB0916578D0 (en) * 2009-09-22 2009-10-28 Malmsten Nils M Polypeptides and uses thereof
US9012168B2 (en) 2010-07-29 2015-04-21 Shire Human Genetic Therapies, Inc. Assays for detection of glycosaminoglycans
EP2809796A4 (de) * 2012-02-01 2016-08-17 Shire Human Genetic Therapies Tests zum nachweis von glykosaminoglykanen
SG11201506886TA (en) 2013-03-14 2015-09-29 Bayer Healthcare Llc Monoclonal antibodies against antithrombin beta complexed with heparin
CN117567597B (zh) * 2024-01-17 2024-03-22 成都艾科斯伦医疗科技有限公司 一种抗凝血酶Ⅲ及抗Xa活性检测试剂盒

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3901917A1 (de) 1989-01-24 1990-07-26 Behringwerke Ag Mutanten von humanem antithrombin iii
DE69032025T2 (de) 1989-02-23 1998-05-20 Blood Res Center Menschlicher elastase-inhibitor
IE902276A1 (en) * 1989-06-26 1991-01-16 Akzo Nv Serpin variants
US5204253A (en) 1990-05-29 1993-04-20 E. I. Du Pont De Nemours And Company Method and apparatus for introducing biological substances into living cells
JP3479539B2 (ja) 1992-04-10 2003-12-15 エーザイ株式会社 ヒトアンチトロンビンｉｉｉ変異体
EP0714308A4 (de) 1993-08-26 1998-07-29 Univ California Methode, zusammensetzungen und vorrichtungen zur verabreichung von nackten polynukleotiden, welche für biologisch aktive peptide kodieren
US5843705A (en) 1995-02-21 1998-12-01 Genzyme Transgenic Corporation Transgenically produced antithrombin III
EP1079791A4 (de) * 1998-05-12 2003-09-03 Susan C Bock Menschliches antithrombin iii und damit verbundene methoden

Also Published As

Publication number Publication date
WO2003101398A8 (en) 2005-03-17
AU2003243381A1 (en) 2003-12-19
WO2003101398A2 (en) 2003-12-11
AU2003243381A8 (en) 2003-12-19
EP1530629B1 (de) 2011-08-31
EP1530629A2 (de) 2005-05-18
US20060259987A1 (en) 2006-11-16
EP1530629A4 (de) 2007-11-07
CA2487901A1 (en) 2003-12-11
US7482139B2 (en) 2009-01-27

Similar Documents

Publication Publication Date Title
ATE433973T1 (de) Azolylaminoazine als inhibitoren von proteinkinasen
EA200870019A1 (ru) Лактамовые соединения и способы их применения
DE69837295D1 (de) Probucolbernsteinsäureester zur Hemmung der Expression von VCAM-1
ECSP056111A (es) Derivados de 2-acilamino-4-feniltiazol, su preparación y aplicación en terapeutica
ATE520674T1 (de) Natriumkanalblocker
BR0308787A (pt) Inibidores de metaloproteinase de n-substituìdos-heteroarilóxi-aril-espiro-pirimidina- 2,4,6-triona
BRPI0414599A (pt) pirrol-indóis substituìdos
NO20071127L (no) Triazoloftalaziner
ATE267830T1 (de) Als cox-hemmer verwendbare sulfonylphenylpyrazol- verbindungen
ATE510534T1 (de) Naltrexonhydrochlorid-zusammensetzungen
IS7721A (is) Píperidín-pýrídasón og þalasón sem PDE4 hemlar
JP2005511541A5 (ja) プロリン後切断プロテアーゼの阻害剤
DE602004017486D1 (de) Substituierte heteroarylbenzofuransäuren
MA28909B1 (fr) Quinazolines utiles en tant que modulateurs de canaux ioniques
ATE495739T1 (de) Pharmazeutische zusammensetzungen und verfahren zur verwendung von levodopa und carbidopa
ATE484508T1 (de) Furylverbindungen
MX337059B (es) Metodos y composiciones para modular la hemostasia.
EA200700702A1 (ru) Аналоги локсапина и способы их применения
ATE516027T1 (de) Orazamid orotat zur vorbeugung von leberschäden
DE60329326D1 (de) Tace inhibitoren
ATE522601T1 (de) Varianten von antithrombin iii
ATE476419T1 (de) Isochinolinon-kaliumkanalinhibitoren
EA200401032A1 (ru) Антиинфарктные молекулы
EP1590666A4 (de) Zusammensetzungen und verfahren für verstärkte apoptose
BRPI0417205A (pt) composições farmacêuticas

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties